$BGMS·8-K

Bio Green Med Solution, Inc. · May 14, 4:25 PM ET

Compare

Bio Green Med Solution, Inc. 8-K

Research Summary

AI-generated summary

Updated

Bio Green Med Solution Reports Results; Press Release May 14, 2026

What Happened
Bio Green Med Solution, Inc. (BGMS) filed a Form 8-K on May 14, 2026 furnishing information about its results of operations and financial condition and making a Regulation FD disclosure. The company attached a press release dated May 14, 2026 as Exhibit 99.1 that communicates the financial results and related disclosures to the public. The filing indicates the furnished information is being provided under Items 2.02 and 7.01 and is included as an exhibit under Item 9.01.

Key Details

  • Filing date: May 14, 2026 (Form 8-K furnished to the SEC).
  • Items reported: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
  • Exhibit: Exhibit 99.1 — Press Release of Bio Green Med Solution, Inc., dated May 14, 2026.
  • The filing states the information is furnished (not “filed”) under the Securities Exchange Act, per standard SEC disclosure practice.

Why It Matters
This filing publicly discloses BGMS’s recent financial results and related information (earnings, revenue and condition of operations) to all investors at the same time, which can affect market perception and share price. Retail investors should review the attached May 14, 2026 press release for the specific figures (revenue, earnings, cash position or guidance) and any management commentary before making investment decisions. The filing is available on the SEC EDGAR site and the company’s investor relations page for detailed review.

Loading document...